Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G N Malavige

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Molecular Pathology : MP|August 2, 2003
Does leptin resistance contribute to infections in patients with diabetes?G N Malavige
Indian Journal of Medical Ethics|December 24, 2005
Doctors, drug companies and medical ethics: a Sri Lankan perspectiveG N Malavige
BMJ (Clinical Research Ed.)|May 17, 2003
Chronic cough. . . .and tropical pulmonary eosinophiliaG N Malavige
The Ceylon Medical Journal|October 23, 2012
Pathogenesis of severe dengue infectionG N Malavige, G Ogg
Transactions of the Royal Society of Tropical Medicine and Hygiene|February 18, 2006
Pathogenesis of liver involvement during dengue viral infectionsS L Seneviratne, G N Malavige, H J de Silva
Clinical and Experimental Immunology|March 28, 2008
Varicella zoster virus glycoprotein E-specific CD4+ T cells show evidence of recent activation and effector differentiation, consistent with frequent exposure to replicative cycle antigens in healthy immune donorsG N Malavige, L Jones, A P Black, et al.
Postgraduate Medical Journal|October 7, 2004
Dengue viral infectionsG N Malavige, S Fernando, D J Fernando, et al.
Clinical and Experimental Dermatology|June 25, 2009
Immune evasion during varicella zoster virus infection of keratinocytesA P Black, L Jones, G N Malavige, et al.
Computational and Mathematical Methods in Medicine|March 16, 2017
Mathematical Modelling of Immune Parameters in the Evolution of Severe DengueM K Premaratne, S S N Perera, G N Malavige, et al.
Clinical and Experimental Dermatology|May 30, 2012
Human antimicrobial peptides LL-37 and human β-defensin-2 reduce viral replication in keratinocytes infected with varicella zoster virusL R Crack, L Jones, G N Malavige, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Molecular Pathology : MP|August 2, 2003
Does leptin resistance contribute to infections in patients with diabetes?G N Malavige
Indian Journal of Medical Ethics|December 24, 2005
Doctors, drug companies and medical ethics: a Sri Lankan perspectiveG N Malavige
BMJ (Clinical Research Ed.)|May 17, 2003
Chronic cough. . . .and tropical pulmonary eosinophiliaG N Malavige
The Ceylon Medical Journal|October 23, 2012
Pathogenesis of severe dengue infectionG N Malavige, G Ogg
Transactions of the Royal Society of Tropical Medicine and Hygiene|February 18, 2006
Pathogenesis of liver involvement during dengue viral infectionsS L Seneviratne, G N Malavige, H J de Silva
Clinical and Experimental Immunology|March 28, 2008
Varicella zoster virus glycoprotein E-specific CD4+ T cells show evidence of recent activation and effector differentiation, consistent with frequent exposure to replicative cycle antigens in healthy immune donorsG N Malavige, L Jones, A P Black, et al.
Postgraduate Medical Journal|October 7, 2004
Dengue viral infectionsG N Malavige, S Fernando, D J Fernando, et al.
Clinical and Experimental Dermatology|June 25, 2009
Immune evasion during varicella zoster virus infection of keratinocytesA P Black, L Jones, G N Malavige, et al.
Computational and Mathematical Methods in Medicine|March 16, 2017
Mathematical Modelling of Immune Parameters in the Evolution of Severe DengueM K Premaratne, S S N Perera, G N Malavige, et al.
Clinical and Experimental Dermatology|May 30, 2012
Human antimicrobial peptides LL-37 and human β-defensin-2 reduce viral replication in keratinocytes infected with varicella zoster virusL R Crack, L Jones, G N Malavige, et al.
Pageof 3